About Dylan Sammut
Dylan joined Irving Levin in October 2018 as a Research and Editorial Associate and is responsible for reporting on mergers and acquisitions in the healthcare sector. He graduated from Alfred University in May 2014 with a degree in English and Political Science. He currently lives in Bridgeport, CT with his fiancé and his overweight cat, Kimba, and in his free time he plays video games, reads, writes, and hikes on the weekends all year around.
by Dylan Sammut | Dec 27, 2022 9:17 am | Medical Office Buildings, Other Services
Rising interest rates will benefit buyers with access to capital Investors focusing on the medical office building (MOB) market in 2023 will be able to take advantage of favorable valuations as interest rates climb. That’s the message from Eric Lewandowski,... Read More »
by Dylan Sammut | Dec 20, 2022 8:38 am | Behavioral Health Care
For the past several years private equity firms and their portfolio companies have driven the behavioral healthcare M&A market, but a new mix of strategic investors have entered the field, from REITs to managed care providers and health systems. Although activity... Read More »
by Dylan Sammut | Dec 14, 2022 3:38 pm | Physician Medical Groups
U.K.-based CARE Fertility has entered the U.S. market with the acquisition of Reach Fertility, or The Reproductive Endocrinology Associates of Charlotte. Based in Charlotte, North Carolina, Reach Fertility is a leader in treating patients with fertility issues. The... Read More »
by Dylan Sammut | Dec 1, 2022 4:08 pm | Hospitals
Tower Health is just not having a good year. According to the Philadelphia Business Journal, Tower Health, which lost $65.6 million in fiscal 2022 and is carrying approximately $1 billion in debt, has been attempting to shed some of its assets as part of its ongoing... Read More »
by Dylan Sammut | Nov 29, 2022 9:24 am | Other Services, Specialty Pharmacies
Significant changes have swept the specialty pharmacy market over the past several years. It was once a niche in the pharmacy industry but has grown significantly in market size. According to a report by Axtria, specialty drug spending is growing and constituted about... Read More »